| Literature DB >> 25984152 |
Edgard Wehbe1, Charbel Salem1, James F Simon1, Sankar D Navaneethan1, Marc Pohl1.
Abstract
Background and objectives. The mesangial deposition of IgA is rarely described with proliferative glomerulonephritis associated with Staphylococcus infection. Recently, this association has been increasingly recognized possibly due to the increased rate of Staphylococcus infection. Design setting, participants and measurements. We report two cases of methicillin-sensitive Staphylococcus aureus bacteremia associated with acute proliferative glomerulonephritis with dominant mesangial deposit of IgA. We searched MEDLINE (1960-2009) for similar reports. We pooled individual patient data and reported descriptive statistics of all published cases. Results. Forty-six cases were included in the final analysis. The mean age of presentation was 59, with a male predominance (84%). Clinical presentation was notable for rapidly progressive glomerulonephritis with nephrotic-range proteinuria and normal complement levels in 52 and 72%, respectively. Methicillin-resistant S. aureus (68%) was the most common pathogen isolated with a latent period ranging from 1 to 16 weeks. Diffuse mesangial proliferation was commonly found with crescentic lesions noted in 35% of the cases. Antimicrobial treatment was associated with renal recovery in 58% of the cases. Need for renal replacement therapy was significantly associated with pre-existing diabetes, hypertension and interstitial fibrosis seen on kidney biopsy. Conclusions. IgA-dominant post-Staphylococcus glomerulonephritis is a rare clinical entity with certain unique clinical and morphologic features. It is difficult to differentiate from primary IgA nephropathy in cases where the infection is not apparent. An acute onset of rapidly progressive glomerulonephritis, with normal complement levels and deposition of mesangial IgA in an elderly patient should raise suspicion for this rare form of glomerulonephritis.Entities:
Keywords: IgA; Staphylococcus; acute glomerulonephritis; complement
Year: 2011 PMID: 25984152 PMCID: PMC4421616 DOI: 10.1093/ndtplus/sfr017
Source DB: PubMed Journal: NDT Plus ISSN: 1753-0784
Fig. 1.(A–C) Renal biopsy findings: (A) light microscopy with endothelial and mesangial cell proliferation with leukocyte infiltration. (B) Immunofluorescence staining for IgA in a granular pattern and mesangial deposition. (C) Electron microscopy with prominent mesangial and occasional subendothelial deposits.
Fig. 2.(A–C) Renal biopsy findings: (A) light microscopy with endothelial and mesangial cell proliferation with leukocyte infiltration. (B) Immunofluorescence staining for IgA in a granular pattern and mesangial deposition. (C) Electron microscopy with mesangial electron-dense deposits.
Clinical characteristics of the 48 cases reported in the literature from 1980–2010a
| Number of patients |
|
| Age (mean) | 21–89 (59.1) |
| Sex (M/F) | 40/8 |
| Creatinine at presentation (mean) | 0.5–9.9 (2.53 mg/dL) |
| Proteinuria | |
| >3 g/day | 25 (52%) |
| <3 g/day | 19 (40%) |
| None specified | 4 (8%) |
| Hematuria | |
| Gross | 8 (17%) |
| Microscopic | 40 (83%) |
| Complement level | |
| Normal | 35 (72%) |
| Low | 12 (25%) |
| NA | 1 (3%) |
| Purpuric lesion | 13 (27%) |
| Hypertension | 7 (14%) |
| Diabetic | 11 (22%) |
| Onset after infection (week) | 1–16 (4.5) |
| Steroids use | 9 (18%) |
| Type of infection | |
| MRSA | 33 (68%) |
| MSSA | 9 (18%) |
| Other | 6 (14%) |
| Outcome | |
| RRT | 16 |
| Death | 7 |
NA, non available.
Predictors of RRT based on the 48 cases reported in the literaturea
| RRT | No RRT | P-value | |
| Age | 66.0 | 61.5 | 0.35 |
| Female | 2 (13) | 6 (19) | 0.70 |
| Hypertension | 5 (31) | 2 (6) | 0.033 |
| Diabetes | 8 (50) | 3 (9) | 0.003 |
| Creatinine at presentation | 3.8 | 1.6 | 0.064 |
| Hematuria (microscopic) | 13 (81) | 27 (84) | 0.99 |
| Proteinuria | 0.66 | ||
| >3 g/day | 7 (44) | 18 (56) | |
| <3 g/day | 7 (44) | 12 (38) | |
| NA | 2 (13) | 2 (6) | |
| Low complement | 7 (44) | 5 (16) | 0.075 |
| Latent period weeks | 2.0 | 4.0 | 0.43 |
| Skin lesion | 2 (13) | 11 (34) | 0.17 |
| Crescent | 3 (20) | 11 (38) | 0.31 |
| Fibrosis | <0.001 | ||
| Absent | 0 (0) | 14 (48) | |
| 1+ | 5 (33) | 13 (45) | |
| 2+ | 7 (47) | 2 (7) | |
| 3+ | 3 (20) | 0 (0) |
NA, non available.
Wilcoxon rank-sum test.